Book a free demo with us
Book Now
IPO
RedHill Biopharma
RedHill Biopharma specializes primarily in gastrointestinal and infectious diseases within the realm of specialty biopharmaceuticals.
Total Fundraised$275.3M
Post-IPO Equity
Post-IPO Debt
Others
2009
Tel Aviv, Israel
ISR
USA
Healthcare
Biotechnology
Health Care
Medical
Pharmaceuticals
51 - 200
Grant
http://www.redhillbio.com/RedHill Biopharma's Stages
Seed
Others
Post-IPO Equity
Post-IPO Debt
Grant
IPO
Funding Types by Funds Raised (in USD)
Content Locked
Login or Register a FREE account to continue browsing our content
Cumulative Funding Raised Over Time
Content Locked
Login or Register a FREE account to continue browsing our content
RedHill Biopharma's Investors by Funding Rounds
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|---|---|---|
Seed | 01 Oct 2009 | Saar Wilf | - 1 Investors |
Others | 03 Nov 2010 | Fidelity Ventures Fischer Pharmaceutical Laboratories Ltd Lautman Foundation Shmuel Kabili | 10M 4 Investors |
Post-IPO Equity | 31 Dec 2013 | Broadfin Capital OrbiMed | 8.5M 2 Investors |
Content Locked
Login or Register a FREE account to continue browsing our content
RedHill Biopharma's
Key Team Members
Social Media
© 2025 Lucidity Insights.
